YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
2.295
-0.069 (-2.92%)
At close: Aug 7, 2026, 4:00 PM EDT
2.290
-0.005 (-0.22%)
After-hours: Aug 7, 2026, 5:05 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $161.38 million as of August 7, 2026. Its market cap has increased by 292.84% in one year.
Market Cap
161.38M
Enterprise Value
158.27M
1-Year Change
292.84%
Ranking
Category
Stock Price
$2.30
ChartMarket Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $161.38M, an increase of 8.78%. That is a compound annual growth rate of 1.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 161.38M | -81.17% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 164.73M |
| Nkarta | 162.77M |
| Acumen Pharmaceuticals | 162.51M |
| OnKure Therapeutics | 162.39M |
| Tenaya Therapeutics | 161.34M |
| Caribou Biosciences | 159.68M |
| Aardvark Therapeutics | 158.61M |
| Milestone Pharmaceuticals | 157.14M |